These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 135421)

  • 1. [The value of the dynamic dehydroepiandrosterone-test compared to the static measurement of total urinary estrogen excretion in the diagnosis of the condition of the feto-placental-unit (author's transl)].
    Kraus H; Lauritzen C; Schneider A; Neumann GK
    Z Geburtshilfe Perinatol; 1976 Oct; 180(5):324-33. PubMed ID: 135421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the DHEA-sulphate-test in pregnancy.
    Bazsa-Kassai Z; Takács I; Körösi T
    Acta Physiol Hung; 1985; 65(4):497-505. PubMed ID: 3160219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endocrine model for the diagnosis of intrauterine growth retardation as demonstrated by the determination of total estrogen and pregnandiol 24-hour urinary excretion in 222 at risk pregnancies.
    Wolfrum R; Bordasch C; Holweg J
    J Perinat Med; 1975; 3(4):248-59. PubMed ID: 1225959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormonal dynamics during pregnancy: critical discussion and clinical interpretations].
    Bélisle S
    Can Med Assoc J; 1978 Dec; 119(11):1307-9. PubMed ID: 153779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of feto-placental unit function test--maternal urinary estrogen/creatine (E/C) ratio (author's transl)].
    Zhonghua Fu Chan Ke Za Zhi; 1979; 14(3):139-45. PubMed ID: 555720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with the dehydroepiandrosterone sulfate test at the end of pregnancy].
    Däsler CG; Kyank HR
    Zentralbl Gynakol; 1975; 97(15):918-23. PubMed ID: 127491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Criteria for the determination of the diagnostic value of feto-placental function tests].
    Curzen P
    Zentralbl Gynakol; 1982; 104(2):107-10. PubMed ID: 7080713
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum alpha-fetoprotein and urinary estrogen/creatinine ratio during pregnancy in the assessment of feto-placental function (author's transl)].
    Zhonghua Fu Chan Ke Za Zhi; 1979; 14(3):146-50. PubMed ID: 95518
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis of placental sulphatase deficiency (author's transl)].
    Bailer P; Gips H; Korte K
    Z Geburtshilfe Perinatol; 1978 Oct; 182(5):384-8. PubMed ID: 83742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma estrogen response to dehydroepiandrosterone sulphate injection in normal and complicated late pregnancy.
    Fraser IS; Leask R; Drife J; Bacon L; Michie E
    Obstet Gynecol; 1976 Feb; 47(2):152-8. PubMed ID: 129714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between morphometric placental studies and clinical biochemical findings in EPH-gestosis].
    Kadner J; Estel C; Günther M; Cimutta B
    Zentralbl Gynakol; 1975; 97(12):705-9. PubMed ID: 127490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal plasma estrogens after dehydroepiandrosterone-sulfate injection into the fetus.
    Gamissans O; Wilson GR; Cuyas J; Davi E; Pujol-Amat P
    Obstet Gynecol; 1977 Oct; 50(4):439-41. PubMed ID: 143623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Total estrogens and estrogen-creatinine ratio in pregnancy].
    Knispel J; Wilken H
    Zentralbl Gynakol; 1976; 98(8):449-54. PubMed ID: 961201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [First experiences with prenatal affection of infantile lung maturation by betamethason (author's transl)].
    Schwenzel W; Jung H; Lahmann H; Etzrodt A; Sticherling C; Korz K; Liedtke B; Chantraine H
    Z Geburtshilfe Perinatol; 1975 Feb; 179(1):45-52. PubMed ID: 1154818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on metabolic pathway from dehydroepiandrosterone sulfate to estrogen in late pregnancy (author's transl)].
    Ichimaru S
    Nihon Naibunpi Gakkai Zasshi; 1975 Sep; 51(9):693-704. PubMed ID: 133827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fetoplacental function by biochemical determinations.
    Chard T
    J Clin Pathol Suppl (R Coll Pathol); 1976; 10():18-26. PubMed ID: 61209
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dehydroepiandrosterone sulfate tolerance test in high-risk pregnancy as evaluation of feto-placental insufficiency].
    Goisis C; Goisis F; Grossi F
    Minerva Ginecol; 1977 May; 29(5):369-89. PubMed ID: 142931
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of intrauterine fetal growth retardation (IUGR) and placental insufficiency by a dehydroepiandrosterone sulfate (DHAS) loading test.
    Rabe T; Hösch R; Runnebaum B
    Biol Res Pregnancy Perinatol; 1983; 4(3):130-6. PubMed ID: 6226324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total maternal urinary estrogen excretion and estrogen/creatinine ratio as placental function tests.
    Varma TR
    Int J Gynaecol Obstet; 1980; 18(5):357-62. PubMed ID: 6110583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the feto-placental function by means of intraamniotic administration of dehydroepiandrosterone-sulphate.
    Dell'Acqua S; Parlati E; Lucisano A; Plotti G; Serri F; Bompiani A
    J Perinat Med; 1979; 7(3):149-60. PubMed ID: 157390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.